title: Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences.
authors.affiliation: Badalona Serveis Assistencials, SA, Department of Planning, Badalona, Spain. asicras@bsa.cat
authors.forename: Antoni
authors.initials: A
authors.lastname: Sicras-Mainar
authors.forename: Ruth
authors.initials: R
authors.lastname: Navarro-Artieda
authors.forename: Milagrosa
authors.initials: M
authors.lastname: Blanca-Tamayo
authors.forename: Victoria
authors.initials: V
authors.lastname: Gimeno-de la Fuente
authors.forename: Jordi
authors.initials: J
authors.lastname: Salvatella-Pasant
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000191:economics; D015283:Citalopram / Q000008:administration & dosage* / Q000191:economics*; D003362:Cost-Benefit Analysis; D003511:Cyclohexanols / Q000008:administration & dosage* / Q000191:economics*; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000191:economics*; D004338:Drug Combinations; D016527:Drug Costs; D005260:Female; D017048:Health Care Costs; D006295:Health Resources / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D013030:Spain; D016896:Treatment Outcome; D000069470:Venlafaxine Hydrochloride; D055815:Young Adult
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D004338:Drug Combinations; D015283:Citalopram; D000069470:Venlafaxine Hydrochloride